+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Imazethapyr Market by Formulation Type (Dry Formulation, Liquid Formulation), Crop Type (Corn, Cotton, Soybean), Application Timing, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6130388
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Introduction

Imazethapyr has emerged as a cornerstone in modern weed management, offering selective post-emergence and pre-emergence control across a variety of legume and broadleaf crops. Since its introduction to agricultural practice, this compound has been lauded for its ability to deliver high efficacy at low use rates, reducing the overall burden of chemical load on the environment. The distinct mode of action, which targets the acetolactate synthase enzyme, provides a critical tool against resistant weed biotypes that challenge conventional herbicide chemistries.

In the context of sustainable agriculture, the adoption of Imazethapyr aligns with integrated weed management strategies that seek to minimize crop losses while preserving ecosystem health. Farmers have observed improved yield stability where this herbicide is strategically rotated with complementary active ingredients. Moreover, its compatibility with conservation tillage practices enhances soil structure and moisture retention, driving long-term agronomic resilience. As market demands evolve, stakeholders from manufacturers to distributors are increasingly focusing on how Imazethapyr fits into a diversified product portfolio designed to meet regulatory requirements and farmer preferences.

The objective of this executive summary is to synthesize key developments and insights, delivering a clear snapshot of emerging opportunities and challenges. By contextualizing regulatory shifts, trade dynamics, segmentation realities, regional nuances, and competitive movements, decision-makers will gain a holistic understanding of the Imazethapyr landscape without requiring additional technical deep dives.

Navigating the Paradigm Shift in Agricultural Herbicide Technologies and Market Dynamics Caused by Innovation and Regulatory Evolution

Transformative Shifts in the Landscape

The Imazethapyr market is undergoing a period of rapid transformation driven by several converging forces. Advances in precision agriculture technologies are enabling farmers to apply herbicides with unprecedented spatial accuracy, reducing input costs while sustaining environmental safeguards. Remote sensing platforms and variable rate application systems are seamlessly integrating with formulation developments to ensure that Imazethapyr achieves optimal coverage even in heterogeneous field conditions.

Regulatory environments are also in flux, as authorities tighten permissible residue limits and emphasize ecological risk assessments. This has prompted manufacturers to innovate around encapsulation and suspension concentrates, designing products that demonstrate lower off-target movement and enhanced rainfastness. Meanwhile, agricultural research institutions and private R&D centers are collaborating to develop crop varieties with improved tolerance tiers, broadening the scope of Imazethapyr usage across corn, cotton, and soybean systems.

Lastly, sustainability imperatives are reshaping distribution and marketing strategies. Stakeholders are investing in circular packaging solutions and digital agronomy platforms that offer real-time application guidance. This holistic evolution is setting the stage for Imazethapyr to retain its position as a critical component in integrated weed management, ensuring that agronomic productivity can be maintained alongside environmental stewardship.

Evaluating the Comprehensive Effects of United States Trade Tariffs on Imazethapyr Supply Chains Distribution Costs and Competitive Positioning in 2025

Cumulative Impact of United States Tariffs 2025

The implementation of new United States tariffs in 2025 has had a cascading effect on the Imazethapyr supply chain and pricing structure. Raw material costs have risen as key intermediates imported from specialized chemical producers in Asia-Pacific become subject to increased duties. These heightened input expenses are being absorbed partially by manufacturers, but a significant portion has inevitably been passed through to distribution partners, altering conventional pricing models.

In response, distributors and agrochemical retailers have reevaluated inventory strategies, shifting to regional manufacturing hubs that offer duty exemptions or preferential trade agreements. Meanwhile, some multi-national players are forging agreements with domestic producers to localize key stages of the value chain, thereby mitigating exposure to cross-border tariff fluctuations. This strategic pivot has also spurred consolidation among distributor networks, as smaller players find it increasingly challenging to maintain margins under the new cost paradigm.

Despite these headwinds, Imazethapyr’s proven performance and broad adoption in major row crops ensure that demand remains robust. However, supply agreements now incorporate more flexible pricing clauses and shorter contract durations to accommodate further policy shifts. As a result, industry stakeholders must keep a close eye on legislative updates and maintain agile procurement practices to safeguard continuity of supply and competitive positioning.

Uncovering Key Segmentation Insights for Imazethapyr Market Based on Formulation Crop Application Timing and Distribution Channel Trends

Key Segmentation Insights

Segmentation by formulation type reveals a bifurcation between dry and liquid offerings. Granular and powder forms continue to serve extensive acreage in regions where equipment for bulk handling is predominant, while emulsifiable concentrate and suspension concentrate variants are gaining traction among precision-driven operators seeking uniform coverage. Each format brings distinct handling and compatibility profiles, demanding tailored technical support to optimize field performance.

When viewed through the lens of crop type, corn maintains its leadership in Imazethapyr usage due to its global footprint and multiple cropping cycles. Cotton growers, however, are intensifying deployment on mid-season weed flushes, leveraging the herbicide’s stability in both post-emergence and early pre-emergence windows. Soybean producers are also exploring split application strategies, combining Imazethapyr with synergists to extend the effective control spectrum against late-emerging broadleaf competitors.

Timing of application emerges as a critical dimension, with post-emergence use dominating in rainfed geographies where unpredictable moisture patterns inhibit reliable soil coverage. Conversely, pre-emergence applications have found favor in irrigation-dependent operations, locking in residual control ahead of weed germination. This differentiation underscores the importance of agronomic advisory services.

Distribution channel analysis highlights the role of agrochemical retailers in delivering personalized recommendations and bundling services. Within direct sales, distributor partnerships and manufacturer sales teams are focusing on building long-term contracts to secure shelf space and technical alignment. Simultaneously, the online retail ecosystem is evolving, with e-commerce platforms and supplier websites offering digital order tracking, seamless payment options, and expanded logistical support to reach under-served landscapes.

Deriving Strategic Regional Perspectives on Imazethapyr Adoption Patterns and Performance Across Americas EMEA and Asia-Pacific Territories

Key Regional Insights

In the Americas, adoption of Imazethapyr continues to be driven by large-scale row crop operations, particularly in the United States and Brazil. Farmers in these territories leverage the herbicide’s compatibility with no-till practices and integrated pest management frameworks, while regulatory bodies maintain rigorous safety protocols that reinforce confidence in product stewardship. North America’s robust distribution infrastructure ensures timely access even during peak planting seasons, reinforcing the region’s status as a strategic growth corridor.

The Europe, Middle East & Africa landscape varies considerably from west to east. In Western Europe, stringent environmental guidelines prompt formulators to innovate around low-volatility technologies and biodegradable adjuvants. Meanwhile, emerging markets in the Middle East and North Africa are characterized by high irrigation intensity and fragmented distribution networks, creating opportunities for digital agri-solutions to bridge information gaps. Sub-Saharan Africa, although at an earlier stage of herbicide integration, shows potential for expansion as regulatory clarity and extension services develop.

Asia-Pacific remains a complex mosaic of mature and nascent markets. Australia’s strict registration processes favor established formulations, while Southeast Asia experiences rising demand for post-emergence solutions that accommodate double cropping cycles. In South Asia, smaller plot sizes and mixed cropping patterns drive growth in user-friendly packaging, whereas China’s consolidation of agrochemical giants is reshaping competitive dynamics. Overall, regional nuances demand highly localized go-to-market strategies that address climatic, regulatory, and agronomic diversity.

Analyzing Competitive Company Strategies Innovations Collaborations and Market Positioning Impacting Imazethapyr Industry Leadership

Key Companies Insights

Leading multinational agrochemical companies have adopted differentiated approaches to maintain their market positions. Major players are investing heavily in R&D to refine Imazethapyr’s efficacy profile, exploring microencapsulation techniques that modulate release rates and enhance crop safety. Collaborative research agreements with agricultural universities and biotech firms are also on the rise, fostering co-development of stacked formulations that integrate herbicide tolerance traits.

Strategic partnerships and licensing deals are reshaping competitive boundaries. Several firms have established regional manufacturing alliances to capitalize on lower production costs and favorable trade terms, while others have pursued acquisitions of specialty formulation houses to broaden their distribution portfolios. Furthermore, joint ventures with digital agronomy providers are enabling companies to bundle prescription-grade application plans alongside the chemical product, reinforcing customer loyalty.

Smaller and mid-sized innovators are differentiating through agility, offering bespoke consultancy services and rapid iteration of trial formulations. By leveraging data analytics and localized field trials, these companies can swiftly adapt to emerging regulatory changes and agronomic challenges. Their nimble structures often allow for faster market entry in underserved geographies, creating pockets of competition that drive overall industry advancement.

Implementing Pragmatic and Actionable Recommendations to Enhance Imazethapyr Adoption Sustainability and Profitability for Industry Leaders

Actionable Recommendations for Industry Leaders

To capitalize on the evolving herbicide landscape, industry leaders should prioritize investment in advanced formulation technologies that reduce environmental impact while enhancing user experience. Strengthening collaboration with precision agriculture platform providers will be essential to deliver integrated solutions valued by tech-savvy growers. Tailored training programs for field agronomists can further drive adoption by demonstrating best practices and troubleshooting real-world application challenges.

Additionally, cultivating strategic supply chain partnerships can shield organizations from tariff volatility and raw material shortages. Establishing redundant sourcing networks, both domestic and international, will enhance resilience. Companies should also consider flexible contracting terms with distribution channels to accommodate shifting trade policies.

Engaging proactively with regulatory agencies across jurisdictions can expedite the approval of novel formulations and facilitate mutual recognition agreements. Finally, embedding sustainability metrics into the product development cycle-such as carbon footprint reduction and stewardship reporting-will align corporate strategies with ESG priorities, reinforcing brand credibility among stakeholders and end users alike.

Outlining Rigorous Research Methodology Framework and Data Collection Processes Underpinning the Imazethapyr Market Intelligence Study

Research Methodology

This study integrates a multi-pronged approach, commencing with exhaustive secondary research across scientific publications, regulatory databases, and patent registries. Legal and environmental compliance documents were reviewed to map the evolving policy landscape. Concurrently, annual reports and investor presentations from major agrochemical firms provided insights into strategic priorities and financial allocations.

Primary research involved in-depth interviews with stakeholders spanning formulators, distributors, agronomists, and regulatory experts. These discussions were structured to validate quantitative findings and uncover emerging trends. Data triangulation was achieved by cross-referencing interview inputs with field trial results and real-time sales data obtained from industry associations.

Quantitative analysis leveraged statistical modeling to segment the market according to formulation type, crop application timing, regional consumption, and distribution channel. Rigorous data validation and consistency checks were performed to ensure reliability. The resulting framework offers a robust foundation for strategic decision making, delivering clarity on the interplay between technological, economic, and regulatory forces shaping the Imazethapyr market.

Summarizing Key Findings and Concluding Observations to Strengthen Strategic Decision Making in the Imazethapyr Market Landscape

Conclusion

The Imazethapyr market stands at a pivotal juncture, shaped by innovative formulation advances, shifting regulatory priorities, and evolving trade policies. Precision agriculture and sustainability imperatives are redefining value propositions, while segmented demand across formulation types, crop systems, and application timings underscores the necessity for targeted strategies. Regional dynamics from the Americas to Asia-Pacific highlight the importance of localized market approaches, and the influence of tariffs in 2025 has reinforced the need for agile supply chain configurations.

Competitive activity is intensifying, with leading corporations and nimble challengers alike investing in partnerships, acquisitions, and digital agronomy integrations. Industry leaders who act swiftly to align product portfolios with environmental and regulatory trends will be best positioned to capture growth opportunities. The insights and recommendations outlined herein equip stakeholders with the analytical foundation required to navigate complexity, optimize resource allocation, and drive sustainable performance in the Imazethapyr market landscape.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Formulation Type
    • Dry Formulation
      • Granular
      • Powder
    • Liquid Formulation
      • Emulsifiable Concentrate
      • Suspension Concentrate
  • Crop Type
    • Corn
    • Cotton
    • Soybean
  • Application Timing
    • Post Emergence
    • Pre Emergence
  • Distribution Channel
    • Agrochemical Retailers
    • Direct Sales
      • Distributor Sales
      • Manufacturer Sales
    • Online Retail
      • Ecommerce Platforms
      • Supplier Websites
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Bayer AG
  • BASF SE
  • Corteva, Inc.
  • Syngenta Group AG
  • FMC Corporation
  • ADAMA Ltd.
  • Nufarm Limited
  • UPL Limited
  • Sumitomo Chemical Co., Ltd.
  • Ishihara Sangyo Kaisha, Ltd.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of imazethapyr-based herbicide programs for soybean yield optimization in North America
5.2. Regulatory harmonization and new EPA guidelines accelerating approvals for imazethapyr-based formulations in the United States
5.3. Development of imazethapyr-tolerant crop hybrids driving increased demand in pulse and legume farming sectors globally
5.4. Integration of precision agriculture technologies with imazethapyr application to enhance weed control efficiency and sustainability outcomes
5.5. Emergence of resistant weed biotypes prompting research into synergistic adjuvants combined with imazethapyr for effective control
5.6. Expansion of contract manufacturing and toll blending partnerships to meet rising global demand for imazethapyr products
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Imazethapyr Market, by Formulation Type
8.1. Introduction
8.2. Dry Formulation
8.2.1. Granular
8.2.2. Powder
8.3. Liquid Formulation
8.3.1. Emulsifiable Concentrate
8.3.2. Suspension Concentrate
9. Imazethapyr Market, by Crop Type
9.1. Introduction
9.2. Corn
9.3. Cotton
9.4. Soybean
10. Imazethapyr Market, by Application Timing
10.1. Introduction
10.2. Post Emergence
10.3. Pre Emergence
11. Imazethapyr Market, by Distribution Channel
11.1. Introduction
11.2. Agrochemical Retailers
11.3. Direct Sales
11.3.1. Distributor Sales
11.3.2. Manufacturer Sales
11.4. Online Retail
11.4.1. Ecommerce Platforms
11.4.2. Supplier Websites
12. Americas Imazethapyr Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Imazethapyr Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Imazethapyr Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bayer AG
15.3.2. BASF SE
15.3.3. Corteva, Inc.
15.3.4. Syngenta Group AG
15.3.5. FMC Corporation
15.3.6. ADAMA Ltd.
15.3.7. Nufarm Limited
15.3.8. UPL Limited
15.3.9. Sumitomo Chemical Co., Ltd.
15.3.10. Ishihara Sangyo Kaisha, Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. IMAZETHAPYR MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL IMAZETHAPYR MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL IMAZETHAPYR MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES IMAZETHAPYR MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES IMAZETHAPYR MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. IMAZETHAPYR MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. IMAZETHAPYR MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. IMAZETHAPYR MARKET: RESEARCHAI
FIGURE 24. IMAZETHAPYR MARKET: RESEARCHSTATISTICS
FIGURE 25. IMAZETHAPYR MARKET: RESEARCHCONTACTS
FIGURE 26. IMAZETHAPYR MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. IMAZETHAPYR MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL IMAZETHAPYR MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL IMAZETHAPYR MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL IMAZETHAPYR MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL IMAZETHAPYR MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL IMAZETHAPYR MARKET SIZE, BY GRANULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL IMAZETHAPYR MARKET SIZE, BY GRANULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL IMAZETHAPYR MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL IMAZETHAPYR MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL IMAZETHAPYR MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL IMAZETHAPYR MARKET SIZE, BY EMULSIFIABLE CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL IMAZETHAPYR MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL IMAZETHAPYR MARKET SIZE, BY SUSPENSION CONCENTRATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL IMAZETHAPYR MARKET SIZE, BY CORN, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL IMAZETHAPYR MARKET SIZE, BY CORN, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL IMAZETHAPYR MARKET SIZE, BY COTTON, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL IMAZETHAPYR MARKET SIZE, BY COTTON, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL IMAZETHAPYR MARKET SIZE, BY SOYBEAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL IMAZETHAPYR MARKET SIZE, BY SOYBEAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL IMAZETHAPYR MARKET SIZE, BY POST EMERGENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL IMAZETHAPYR MARKET SIZE, BY POST EMERGENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL IMAZETHAPYR MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL IMAZETHAPYR MARKET SIZE, BY PRE EMERGENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL IMAZETHAPYR MARKET SIZE, BY AGROCHEMICAL RETAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL IMAZETHAPYR MARKET SIZE, BY AGROCHEMICAL RETAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL IMAZETHAPYR MARKET SIZE, BY MANUFACTURER SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL IMAZETHAPYR MARKET SIZE, BY MANUFACTURER SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL IMAZETHAPYR MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL IMAZETHAPYR MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL IMAZETHAPYR MARKET SIZE, BY SUPPLIER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL IMAZETHAPYR MARKET SIZE, BY SUPPLIER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES IMAZETHAPYR MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES IMAZETHAPYR MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 98. CANADA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 99. CANADA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 100. CANADA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 101. CANADA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 103. CANADA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 104. CANADA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 105. CANADA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 106. CANADA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 107. CANADA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. CANADA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. CANADA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 110. CANADA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 111. CANADA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 112. CANADA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 116. MEXICO IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 119. MEXICO IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 122. MEXICO IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 123. MEXICO IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 128. MEXICO IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA IMAZETHAPYR MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 195. GERMANY IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 196. GERMANY IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 197. GERMANY IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 198. GERMANY IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 202. GERMANY IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 203. GERMANY IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 204. GERMANY IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 205. GERMANY IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. GERMANY IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 208. GERMANY IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 209. GERMANY IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 210. GERMANY IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 211. FRANCE IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 212. FRANCE IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 213. FRANCE IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 214. FRANCE IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 216. FRANCE IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 217. FRANCE IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 219. FRANCE IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 220. FRANCE IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 221. FRANCE IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. FRANCE IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 224. FRANCE IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 225. FRANCE IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 226. FRANCE IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 243. ITALY IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 244. ITALY IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 245. ITALY IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 246. ITALY IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 248. ITALY IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 249. ITALY IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 250. ITALY IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 251. ITALY IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 252. ITALY IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 253. ITALY IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ITALY IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. ITALY IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 256. ITALY IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 257. ITALY IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 258. ITALY IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 259. SPAIN IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 261. SPAIN IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. SPAIN IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 264. SPAIN IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 265. SPAIN IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 266. SPAIN IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 267. SPAIN IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 268. SPAIN IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 269. SPAIN IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SPAIN IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 272. SPAIN IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 273. SPAIN IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 274. SPAIN IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 323. DENMARK IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 324. DENMARK IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 325. DENMARK IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 326. DENMARK IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 327. DENMARK IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 328. DENMARK IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 329. DENMARK IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 330. DENMARK IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 331. DENMARK IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 332. DENMARK IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 333. DENMARK IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. DENMARK IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. DENMARK IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 336. DENMARK IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 337. DENMARK IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 338. DENMARK IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 339. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 340. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY APPLICATION TIMING, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 353. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2018-2024 (USD MILLION)
TABLE 354. NETHERLANDS IMAZETHAPYR MARKET SIZE, BY ONLINE RETAIL, 2025-2030 (USD MILLION)
TABLE 355. QATAR IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2018-2024 (USD MILLION)
TABLE 356. QATAR IMAZETHAPYR MARKET SIZE, BY FORMULATION TYPE, 2025-2030 (USD MILLION)
TABLE 357. QATAR IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2018-2024 (USD MILLION)
TABLE 358. QATAR IMAZETHAPYR MARKET SIZE, BY DRY FORMULATION, 2025-2030 (USD MILLION)
TABLE 359. QATAR IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2018-2024 (USD MILLION)
TABLE 360. QATAR IMAZETHAPYR MARKET SIZE, BY LIQUID FORMULATION, 2025-2030 (USD MILLION)
TABLE 361. QATAR IMAZETHAPYR MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
TABLE 362. QATAR IMAZETHAP

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Imazethapyr market report include:
  • Bayer AG
  • BASF SE
  • Corteva, Inc.
  • Syngenta Group AG
  • FMC Corporation
  • ADAMA Ltd.
  • Nufarm Limited
  • UPL Limited
  • Sumitomo Chemical Co., Ltd.
  • Ishihara Sangyo Kaisha, Ltd.